MedMira Laboratories

NCT00292812

Clinical Effects of a Nucleotides-Supplemented Infant Formula

NCT01958931

Evaluate the Utility of the ProLung Test as Adjunctive to CT Scan in the Diagnosis of Lung Cancer

NCT00836771

Infant Formula Supplemented With Probiotic Microorganisms and/or Prebiotic.

NCT01140243

Infant Formula Supplemented With a Special Fat Formulation for Premature Infants Following Discharge From Hospital

NCT01566682

A Multi-Center Trial of the ProLung Test™

NCT02190305

Rapid Diagnostics for HIV and Hepatitis

NCT02190578

Clinical Performance of Reveal G4 Rapid HIV-1 Antibody Test

NCT03993028

The Effects of Sex, Body Mass Index, Day-to-Day Subject Variability for the ProLung Test and Variability of a Single Device When Volume-Averaged Thoracic Bioconductance is Measured With the ProLung Test

NCT03607812

Diagnosis and Management of Arterial Hypertension for Algerian Patients in Current Medical Practice

NCT04134520

Establish ProLung Test Measurement Collection Protocol for Future Studies.

NCT04412980

Ionized Magnesium for Monitoring of Citrate-anticoagulated CVVHD

NCT05831098

Evaluation of the Sensitivity, Specificity, and Utility of the Reveal® TP (Syphilis) Antibody POCT

NCT06586905

A Cross-sectional Investigational Study to Evaluate the Sensitivity, Specificity, and Utility of the MedMira Inc. Multiplo® Complete Syphilis (TP/nTP) Antibody Test (POCT) to Diagnose Infectious Syphilis in Participants Attending the Sexual Health Clinic in Ottawa, Ontario.